Charles River Laboratories International Inc $58.17

up +0.20


22/4/2014 06:40 PM  |  NYSE : CRL  
Industries : Health Services / Medical Laboratories & Research
Get Trend Analysis Icon Get CRL Trend Analysis - it has outperformed the S&P 500 by 17%

Partner Headlines

  1. Charles River Aims To Be 'One-Stop Shop' With Buyout

    IBD
  2. Morgan Stanley Feels Confidence in Charles River Laboratories Following ...

    Benzinga
  3. CHARLES RIVER LABS

    IBD
  4. Earnings Scheduled For February 11, 2014

    Benzinga
  5. Parexel Plunges After 3 CROs Report Earnings

    IBD
  6. Parexel Stock Rises As Analyst Upgrades, Touts CROs

    IBD
  7. Medical Research Firms Tap Drug Development Trend

    IBD
  8. Medical Research Firms Tap Drug Development Trend

    IBD
  9. Earnings Scheduled For February 13, 2013

    Benzinga
  10. Robert Olstein's Largest New Stock Picks

    GuruFocus
  11. UPDATE: Sterne Agee Reiterates Buy Rating, Raises PT on Charles River Laboratories

    Benzinga
  12. Weekly CFO Sells HIGHLIGHT: TMO, BLOX, VRSK, CRL, INGR, GWRE

    GuruFocus
  13. Charles River Laboratories International Inc (CRL) Corp. ...

    GuruFocus
  14. Charles River Labs Closes Purchase of Majority Ownership of Vital River

    Benzinga
  15. UPDATE: JP Morgan Upgrades Charles River Laboratories to Overweight on ...

    Benzinga
  16. Mid-Afternoon Market Update: Bernanke Press Conference Leads to Drop in ...

    Benzinga
  17. Mid-Day Market Update: Fed to Continue Stimulus, Markets Rise

    Benzinga
  18. UPDATE: ISI Group Cuts PT to $39 on Charles River Laboratories Following ...

    Benzinga
  19. Top 4 NYSE Stocks In The Biotechnology Industry With The Highest ROA

    Benzinga
  20. Charles River Laboratories International Reports Operating Results (10-Q)

    GuruFocus
  21. UPDATE: Jefferies & Company Reiterates Hold Rating, Raises PT on Charles ...

    Benzinga
  22. Top 4 NYSE Stocks In The Biotechnology Industry With The Highest Revenue ...

    Benzinga
  23. Charles River Laboratories International (CRL) Chairman, President and ...

    GuruFocus
  24. Charles River Laboratories International (CRL) Chairman, President and ...

    GuruFocus
  25. Charles River Laboratories International (CRL) Corp. ...

    GuruFocus
  26. Charles River Opens New Biomedical Diagnostic Facility

    Benzinga
  27. Charles River Acquires Accugenix

    Benzinga
  28. Charles River Laboratories International Reports Operating Results (10-Q)

    GuruFocus
  29. Charles River Laboratories International (CRL) Corp. ...

    GuruFocus
  30. Charles River Laboratories International (CRL) Chairman, President and ...

    GuruFocus
  31. Charles River Laboratories International (CRL) Chairman, President and ...

    GuruFocus
  32. Charles River Laboratories International (CRL) Chairman, President and ...

    GuruFocus
  33. Charles River Laboratories International (CRL) Chairman, President and ...

    GuruFocus
  34. Health Care Sector Wrap

    FoxBusiness
  35. Charles River Laboratories International (CRL) Corp. ...

    GuruFocus
  36. Charles River Labs

    IBD
  37. Ariel Funds Top Buys: "We think like Halvorsen: CRL is a buy"

    GuruFocus
  38. Stocks I Can Buy Much Cheaper Than Halvorsen Did

    GuruFocus
  39. Ken Heebner Top Holdings: AAPL Is a Buy at $380

    GuruFocus
  40. Benzinga's M&A Chatter for Tuesday January 10, 2012

    Benzinga
  41. Charles River rises on sale talk

    IBD
  42. JP Morgan Reiterates BioMimetic Therapeutics Neutral

    Benzinga
  43. Citigroup Lowers PT on Charles River Laboratories to $31

    Benzinga
  44. UPDATE: Deutsche Bank Lowers PT on Charles River Laboratories to $28

    Benzinga
  45. Deutsche Bank Maintains Hold After Charles River Releases 2012 Guidance

    Benzinga
  46. Notable Call Options Activity in Charles River Laboratories

    Benzinga
Trading Center